Jasper Therapeutics, Inc. (JSPR) dividend history

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$13.68+0.31 (+2.32%)

Close on Nov 13, 2026Market cap $455.20MP/E –Yield –

Dividends

No dividend per share appears in Jasper Therapeutics's annual filings since fiscal 2019.

See a number that looks wrong?